Sign In to Follow Application
View All Documents & Correspondence

A Composition Comprising Laminarin, And A Small Molecule And Uses Thereof

Abstract: The present disclosure provides a composition comprising laminarin and N-(4-chloro-2-methylphenyl)-4-(2-naphthyl)-2,4-dioxo-3-(3-oxo-1,3-dihydro-2-benzofuran-1-yl) butanamide, which at particular weight ratios has surprising beneficial characteristics that finds use in skin care applications, particularly to inhibit visible signs of skin aging.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
18 January 2016
Publication Number
29/2017
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
lsmds@lakshmisri.com
Parent Application

Applicants

ITC LIMITED
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058, India

Inventors

1. HARI VARMA, Ramya
ITC Life Sciences & Technology Centre #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058, India
2. SIRIGERI JOIS, Prashanth
ITC Life Sciences & Technology Centre #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058, India
3. MUTHAIYAH, Balu
ITC Life Sciences & Technology Centre #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058, India
4. CHANDRASEKHARAN, Lakshmanan Chittur
ITC Life Sciences & Technology Centre #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058, India
5. BANDYOPADHYAY, Balaji
ITC Life Sciences & Technology Centre #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058, India

Specification

Claims:1. A composition comprising:
a. laminarin; and
b. N-(4-chloro-2-methylphenyl)-4-(2-naphthyl)-2,4-dioxo-3-(3-oxo-1,3-dihydro-2-benzofuran-1-yl) butanamide,
wherein laminarin to N-(4-chloro-2-methylphenyl)-4-(2-naphthyl)-2,4-dioxo-3-(3-oxo-1,3-dihydro-2-benzofuran-1-yl) butanamide w/w ratio in said composition is in the range of 0.16:1-20:1.
2. The composition as claimed in claim 1, wherein laminarin to N-(4-chloro-2-methylphenyl)-4-(2-naphthyl)-2,4-dioxo-3-(3-oxo-1,3-dihydro-2-benzofuran-1-yl) butanamide w/w ratio in said composition is in the range of 0.7:1-17:1.
3. The composition as claimed in claim 2, wherein laminarin to N-(4-chloro-2-methylphenyl)-4-(2-naphthyl)-2,4-dioxo-3-(3-oxo-1,3-dihydro-2-benzofuran-1-yl) butanamide w/w ratio in said composition is 1:1.
4. The composition as claimed in claim 2, wherein laminarin to N-(4-chloro-2-methylphenyl)-4-(2-naphthyl)-2,4-dioxo-3-(3-oxo-1,3-dihydro-2-benzofuran-1-yl) butanamide w/w ratio in said composition is 16.66:1.
5. The composition as claimed in any of the claims 1-4, further comprises suitable carriers, diluents, and excipients.
6. A method of inhibiting skin aging, said method comprising:
a. obtaining a composition as claimed in any of the claims 1-5; and
b. contacting said composition with skin,
wherein said method inhibits skin aging.
7. The method as claimed in claim 6, wherein said method inhibits appearance of wrinkles, fine lines, or loss of skin elasticity.
8. A method of preparing a composition as claimed in any of the claims 1-5.
9. The composition as claimed in any of the claims 1-5, wherein said composition is for topical application.
10. A composition as claimed in any of the claims 1-5 for use in preparing topical formulations for inhibiting skin aging.
, Description:As Attached

Documents

Application Documents

# Name Date
1 Form 5 [18-01-2016(online)].pdf 2016-01-18
2 Form 3 [18-01-2016(online)].pdf 2016-01-18
3 Drawing [18-01-2016(online)].pdf 2016-01-18
4 Description(Complete) [18-01-2016(online)].pdf 2016-01-18
5 201641001819-Power of Attorney-250216.pdf 2016-07-05
6 201641001819-Form 1-250216.pdf 2016-07-05
7 201641001819-Correspondence-F1-PA-250216.pdf 2016-07-05
8 201641001819-FORM 18 [03-12-2019(online)].pdf 2019-12-03
9 201641001819-FER.pdf 2020-07-27

Search Strategy

1 output(3)E_24-07-2020.pdf